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Abstract
Objective and Importance: despite recent progress in imaging, it is still difficult to distinguish between pituitary
adenoma and hyperplasia, even using Magnetic Resonance Imaging (MRI) with gadolinium injection. We describe
an example of reactive pituitary hyperplasia from primary hypothyroidism that mimicked a pituitary macroadenoma
in a child.
Clinical Presentation: a 10 year old boy presented with headache and statural growth arrest. MRI revealed an
intrasellar and suprasellar pituitary mass. Endocrine evaluation revealed primary hypothyroidism.
Intervention: the patient was started on levothyroxine with resolution of the mass effect.
Conclusion: primary hypothyroidism should be considered in the differential diagnosis of solid mass lesions of the
pituitary gland. Examination of thyroid function in patients with sellar and suprasellar masses revealed by MRI may
avoid unnecessary operations which can cause irreversible complications.
Background
There are many causes of sellar and suprasellar mass,
and pituitary enlargment secondary to primary
hypothyroidism has been previously described [1-5]. It
results from the loss of thyroxine feedback inhibition
and the subsequent overproduction of thyrotropin-
releasing hormone (TRH) [6]. Despite recent progress in
imaging techniques, it is not possible to distinguish
between TSH-producing macroadenoma and hyperplasia
of pituitary thyrotroph cells on CT and MR scans. In
such cases, repeat MRI after therapy with thyroxine may
provide a definitive diagnosis and eliminate unnecessary
surgery: unlike adenoma, pituitary hyperplasia resolves
after thyroid hormone replacement therapy [2].
Case Presentation
History and Physical Examination
A 10 year old boy, born at term in Morocco from non-
consanguineous parents after an uncomplicated preg-
nancy, presented at his local hospital with occipital
headache over the last three months and height growth
arrest: during the previous 2 years he had grown 1 cm,
declining from the 75-90
th percentile to the 25
th,w h i l e
his weight had passed from the 50
th to the 75
th percen-
tile in the last year. He did not complain of vomiting,
tiredness or any other symptoms.
His past and familial history was unremarkable and his
cognitive development normal. On physical examination,
he presented with height 136 cm (25
th percentile),
weight 42 kg (75
th percentile), prepubertal status, blood
pressure 120/67 mmHg, pulse rate 72 bpm, and non-
palpable thyroid gland. Because of persistent headache
he was referred to the neurologist at his local hospital
and the examination was normal, as were the fundus
oculi and visual fields.
Radiographic and laboratory data
Cranial Magnetic Resonance Imaging (MRI) was per-
formed to rule out an organic lesion and an intrasellar
and suprasellar pituitary mass was detected. The enlarg-
ment was isointense to gray matter, extended on the
suprasellar cistern with mild compression of the optic
chiasm. The pituitary stalk and posterior pituitary were
dislocated. After gadolinium the mass homogeneously
enhanced (Figure 1).
After endocrine consultation, blood tests were done:
full blood count, erythrocyte sedimentation rate, renal
and liver function and anti-coeliac screening were
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markedly heterogeneous echo texture and hypo-echoic
areas. The color Doppler study revealed diffuse hyper-
vascolarization of the gland. The picture was consistent
with late-stage chronic thyroiditis. Based on clinical his-
tory and laboratory data, a diagnosis of primary
hypothyroidism consequent to chronic autoimmune
(Hashimoto’s) thyroiditis was made and the pituitary
mass was attributed to secondary hyperplasia. The
patient was started on levothyroxine at 50 ug/day. IGF-I
and thyroid function had returned to the normal range
after 3 months (Table 1). Height growth velocity
increased (7 cm/year) and at the last visit, at 11 years,
the boy’s height was on the 50
th percentile and he was
no longer complaining of headache. A follow-up MRI
scan 5 months after levothyroxine replacement showed
resolution of the mass effect (Figure 2).
Discussion
Due to the loss of thyroxine feedback inhibition and the
subsequent overproduction of thyrotropin-releasing hor-
mone (TRH), long-standing hypothyroidism results in
hyperplasia of the thyrotroph cells and subsequent
enlargement of the pituitary gland [6]. The incidence of
pituitary hyperplasia in patients with hypothyroidism
varies from 25% to 81% [7], high incidence (70%) is
reported in patients with TSH levels ≥50 μIU/m 8 l [8].
Because TRH also has a weak stimulatory effect on lac-
totroph cells, mild to moderate hyperprolactinemia may
also occur in about three-quarters of patients [7]. Never-
theless in our patient the slight increase in prolactin was
probably due to the compression of the infundibulum
by the mass, rather than to lactotroph hyperplasia.
Children with pituitary hyperplasia and primary
hypothyroidism rarely present with neurological symp-
toms secondary to sellar expansion (3%). Their complaints
at presentation are associated with hypothyroidism and
abnormal puberty [7]. Most children present with symp-
toms of growth arrest due to primary hypothyroidism, and
growth hormone (GH) production may be decreased
because thyroxine is one of the factors stimulating GH
synthesis [1]. Long-standing primary hypothyroidism may
also lead to irreversible pituitary injury, which can lead to
a deficiency in one or more pituitary hormones [3]. There-
fore in our patient persistent headache has to be attributed
to hypothyroidism, even if the exact mechanism is not
clear. Moreover reduced IGF-1 was probably secondary to
transitory reduced GH synthesis.
Despite recent progress in imaging, it is still difficult
to distinguish between a pituitary adenoma and hyper-
plasia, even using MRI with gadolinium injection. On
imaging studies, secondary pituitary hyperplasia is often
characterized by a homogeneously enhancing lesion that
may progress rapidly following the onset of a hypothyr-
oid state [9]. Interpretation of a pituitary mass without
an endocrine investigation can lead to unnecessary sur-
gery which can cause irreversible complications [9-11].
Figure 1 A-E. Pretreatment sagittal (A, B) and coronal (C-E) T1-
weighted MR images show diffuse enlagement of the pituitary
gland, that extends into the suprasellar cystern with mild
compression of the optic chiasm and of the posterior
neurohypophyseal lobe, which keeps its normal bright signal.
After intravenous Gadolinum administration (B, D) the mass
demonstrate homogeneous enhancement; the pituitary stalk (E) is
raised but still along the midline.
Table 1 Hormonal pattern at diagnosis and during follow up
Parameter Before therapy 3 months later 6 months later Normal range
TSH, mU/L 589 13.8 4.3 0.20-4.50
Free T4, pmol/L 1.5 13.9 14.2 12-22
Free T3, pmol/L 2.2 6.2 5.4 3.8-8.6
IGF-I, nmol/L 8.6 24.66 n.a. 11.64-34.1
PRL, nmol/L 1.23 0.51 n.a. 0.17-0.64
TSH: thyroid-stimulating hormone; T4: thyroxine; T3: triiodothyronine; IGF-I: insulin-like growth factor I; PRL: prolactin. Results are expressed in international unit.
For free T4 to convert to ng/dL divide by 12.86; for free T3 to convert to ng/dL divide by 1.536, for IGF-I to convert to ng/mL divide by 0.1307, for PRL to convert
to ng/mL divide by 0.0426. N.a.: not available.
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be made by means of inappropriatey normal/high range
values of T3 and T4. Nevertheless the sequence and
time course of hypothyroidism and pituitary hyperplasia
have not been clarified [5]. Concomitant diagnosis of
hypothyroidism and pituitary hyperplasia are described
in the literature [12], but two additional scenarios have
been reported: a) normal thryoid function may be found
in patients with a pituitary mass revealed by MR ima-
ging. Re-examination a few weeks later is recommended
because initial normal thyroid function may mask the
diagnosis of hypothyroidism-related pituitary hyperplasia
in these patients [9]; b) in other patients rapid progres-
sion of hyperplasia may develop after hypothyroidism
[12].
Thyroid hormone replacement therapy led to a
decrease in the size of the gland in 85% of patients with
pituitary enlargement who underwent follow-up MR
examinations [8]. Surgery should be reserved for decom-
pression of the optic chiasm or to obtain a pathological
diagnosis in the case of a pituitary mass which does not
respond to, or worsens under, thyroid hormone replace-
ment [3]. In our patient, baseline thyroid function tests
were consistent with primary hypothyroidism secondary
to chronic autoimmune thyroiditis and repeat pituitary
MRI after 5 months of levothyroxine therapy revealed
complete regression of the pituitary mass. Based on the
combined clinical findings, hormonal studies, and repeat
MRI findings, the diagnosis of pituitary hyperplasia sec-
ondary to primary autoimmune hypothyroidism was
made.
Conclusions
Primary hypothyroidism should be considered in the dif-
ferential diagnosis of solid mass lesions of the pituitary
gland, particularly in children with short stature. Exami-
nation of thyroid function in patients with sellar and
suprasellar masses revealed by MR imaging may avoid
unnecessary operations.
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